Molecular pathogenesis of multiple sclerosis

Journal of Neuroimmunology

Volumn 100, Issue 1-2, 1999, Pages 252-259

  Bar Or, Amit ^a   Oliveira, Enedina M L ^a   Anderson, David E ^a   Hafler, David A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adhesion molecules; Autoreactive T cells; B7 1 (CD80); B7 2 (CD86); Blood brain barrier; Central nervous system; Cerebrospinal fluid; Chemokines; Costimulation; EAE; Extracellular matrix; Interferon ; Matrix metalloproteinases; MBP; Molecular mimicry; Multiple sclerosis; Myelin epitopes; Pathogenesis; PLP; Primary progressive; Proinflammatory cytokines; Relapsing remitting; Secondary progressive; Th1; Th2

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CYCLOPHOSPHAMIDE; CYTOKINE; GELATINASE B; INTEGRIN RECEPTOR; INTERFERON BETA SERINE; INTERLEUKIN 12; MATRIX METALLOPROTEINASE; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; MYELIN PROTEIN; RANTES; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

AUTOIMMUNITY; CEREBROSPINAL FLUID; HUMAN; INFLAMMATORY CELL; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELAPSE; REVIEW; T LYMPHOCYTE ACTIVATION; WHITE MATTER;

EID: 0033400631     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00193-9     Document Type: Article

References (96)

1. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature. 383(6603):1996;787-793.
2. Adams C.W., Poston R.N., Buk S.J. Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis. J. Nat. Sci. 92:1989;291-306.
3. Aloisi F., Borcellino G., Samoggia P., Testa U., Chelucci C., Russo G., Peschle C., Levi G. Astrocyte cultures from human embryonic brain: characterization and modulation of surface molecules by inflammatory cytokines. J. Neurosci. Res. 32:1992;494-506.
4. Anthony D.C., Miller K.M., Fearn S., Towsend M.J., Opdenakker G., Wills G.M. Matrix metalloproteinase expression in an experimentally induced DTH model of MS in the rat CNS. J. Neuroimmunol. 87:1998;62-72.
5. Baron J.L., Madri J.A., Ruddle N.H., Hashim G., Janeway C.A. Jr. Surface expression of αV4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177:1993;57-68.
6. Begolka W.S., Vanderlugt C.L., Rahbe S.M., Miller S.D. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis. J. Immunol. 161(8):1998;4437-4446.
7. Black R.A., Rauch C.T., Kozlosky C.J., Peschon J.J., Slack J.L., Wolfson M.F., Castner B.J., Stocking K.L., Reddy P., Srinivasam S., Nelson N., Boiani N., Schooley K.A., Gerhart M., Davis R., Fitzner J.N., Johnson R.S., Paxton R.J., March C.J., Cerreti D.P. A metalloprotienase disintegrin that releases TNF-α from cells. Nature. 385:1997;729-733.
8. Bo L., Peterson J.W., Mork S., Hoffman P.A., Gallatin W.M., Ransohoff R.M., Trapp B.D. Distribution of immunoglobulin family members ICAM-1, -2, -3 and the β2 integrin LFA-1 in multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 55:1996;1060-1072.
9. Bright J.J., Musuro B.F., Du C., Sriram S. Expression of IL-12 in CNS and lymphoid organs of mice with experimental allergic encephalitis. J. Neuroimmunol. 82:1998;22-30.
10. Brosnan C.F., Cannella B., Battistini L., Raine C.S. Cytokine localization in MS lesions: correlation with adhesion molecule expression and reactive nitrogen species. Neurology. 45:1995;S16-S21.
11. Cannella B., Raine C.S. The adhesion molecule and cytokine profile in MS lesions. Ann. Neurol. 37:1995;424-435.
12. Carrizosa A.M., Nicholson L.B., Farzan M., Southwood S., Sette A., Sobel R.A., Kuchroo V.K. Expansion by self antigen is necessary for the induction of experimental autoimmune encephalomyelitis by T cells primed with a cross-reactive environmental antigen. J. Immunol. 161:1998;3307-3314.
13. Colombo E., Bauki K., Tatum A.H., Dancher J., Ferrante P., Murray R.S., Philips P.E., Pearl A. Comparative analysis of antibody and cell-mediated autoimmunity to transaldolase and myelin basic protein in patients with multiple sclerosis. J. Clin. Invest. 99:1997;1238-1250.
14. Comabella M., Balashov K., Issazadeh S., Smith D., Weiner H.L., Khoury S.J. Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy. J. Clin. Invest. 102:1998;671-678.
15. Constantinescu C.S., Wysocka M., Hilliard B., Ventura E.S., Lavi E., Trinchieri G., Rostami A. Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis. J. Immunol. 161(9):1998;5097-5104.
16. Cuzner M.L., Davison A.N., Rudge P. Proteolytic enzyme activity of blood leukocytes and CSF in MS. Ann. Neurol. 4:1978;337-344.
17. Cuzner M.L., Gveric D., Strand C., Loughlim A.J., Palmer C., Opdenakker G., Newcombe J. The expression of tissue-type plasminogen activator, matrix metalloproteinases and endogenous inhibitors in the CNS in MS: comparison of stages in lesion evolution. J. Neuropathol. Exp. Neurol. 55:1996;1194-1204.
18. + T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 88:1991;6403-6407.
19. + T lymphocytes. J. Immunol. 151:1993;2368-2379.
20. Elices M.J., Osborn L., Takada Y., Crouse C., Luhowskyj S., Hemler M.E., Lobb R.R. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell. 60:1990;577-584.
21. Foster C.A. VCAM-1α4-integrin adhesion pathway: therapeutic target for allergic inflammatory disorders. J. Allergy Clin. Immunol. 98:1996;S270-S277.
22. Frohman E.M., Frohman T.C., Dustin M.L., Vayuvegula B., Choi B., Gupta A., van den Noort S., Gupta S. The induction of ICAM-1 expression on human fetal astrocytes by interferon-γ, tumor necrosis factor-α, lymphotoxin and IL-1: relevance to intracerebral antigen presentation. J. Neuroimmunol. 23:1989;117-124.
23. + B cells in active multiple sclerosis and reversal by interferon-1b therapy. J. Clin. Invest. 99:1997;2664-2671.
24. Gijbels K., Masure S., Carton H., Opdenakker G. Gelatinase in the CSF of patients with MS and other inflammatory neurological disorders. J. Neuroimmunol. 41:1992;29-34.
25. Hartung H.P., Jung S., Stoll G., Zielasck J., Schmidt B., Archelos J.J., Tokya K.V. Inflammatory mediators in demyelinating disorders of the CNS and PNS. J. Neuroimmunol. 40:1992;197-210.
26. Hofman F.M., Hinton D.R., Johnson K., Merrill J.E. Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 170(2):1989;607-612.
27. Hvas J., McLean C., Justesen J., Kannourakis G., Steinman L., Oksenberg J.R., Bernard C.C. Perivascular T cells express the pro-inflammatory chemokine RANTES mRNA in multiple sclerosis lesions. Scand. J. Immunol. 46:1997;195-203.
28. Issazadeh S., Navikas V., Schaub M., Sayegh M., Khoury S. Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo. J. Immunol. 161(3):1998;1104-1112.
29. Karandikar N.J., Vanderlugt C.L., Bluestone J.A., Miller S.D. Targeting the B7/CD28:CTLA-4 costimulatory system in CNS autoimmune disease. J. Neuroimmunol. 89:1998;10-18.
30. Karandikar N.J., Vanderlugt C.L., Eagar T., Tan L., Bluestone J.A., Miller S.D. Tissue-specific up-regulation of B7-1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis. J. Immunol. 161:1998;192-199.
31. Karpus W.J., Kennedy K.J. MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation. J. Leukocyte Biol. 62:1997;681-687.
32. Karpus W.J., Ransohoff R.M. Cutting Edge Commentary: chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis. J. Immunol. 161:1998;2667-2671.
33. Karpus W., Lukacs N.W., McRae B.L., Strieter R.M., Kunkel J.L., Miller S.D. An important role for the chemokine macrophage inflammatory protein-1 in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J. Immunol. 155:1995;5003-5010.
34. Khoury S.J., Hancock W.W., Weiner H.L. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176(5):1992;1355-1364.
35. Kieseier B.C., Seifert T., Giovannoni G., Hartung H.P. Matrix metalloproteinases in inflammatory demyelination: targets for treatment. Neurology. 53:1999;20-25.
36. Kuchroo V.K., Martin C.A., Greer J.M., Ju S.-T., Sobel R.A., Dorf M.E. Cyokines and adhesion molecules contribute the ability of myelin proteolipid protein-specific T cell clones to mediate EAE. J. Immunol. 151:1993;4371-4382.
37. Kuchroo V.K., Das M.P., Brown J.A., Ranger A.M., Zamvil S.S., Sobel R.A., Weiner H.L., Nabavi N., Glimcher L.H. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell. 80:1995;707-718.
38. Lee S.J., Benveniste E.N. Adhesion molecule expression and regulation on cells of the CNS. J. Neuroimmunol. 98:1999;77-88.
39. Lee M.A., Palace J., Stabler G., Ford J., Gearing A., Miller K. Serum gelatinase B, TIMP-1 and TIMP-2 levels in MS: a longitudinal clinical and MRI study. Brain. 122:1999;191-197.
40. Lenschow D.J., Walunas T.L., Bluestone J.A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:1996;233-258.
41. Leonard J.P., Waldburger K.E., Schaub R.G., Smith T., Hewson A.K., Cuzner M.L., Goldman S.J. Regulation of the inflammatory response in animal models of multiple sclerosis by interleukin-12. Crit. Rev. Immunol. 17:1997;545-553.
42. Leppert D., Waubant E., Galardy R., Bunnett N.W., Hauser S.L. T cell gelatinases mediate basement membrane transmigration in vitro. J. Immunol. 154:1995;4379-4389.
43. Leppert D., Waubant E., Burk M.R., Oksenberg J.R., Hauser S.L. Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in MS. Ann. Neurol. 40:1996;846-852.
44. Leppert D., Ford J., Stabler G., Grygar C., Lienert C., Huber S., Miller K.M., Hauser S.L., Kappos L. Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phase of MS. Brain. 121:1998;2327-2334.
45. Liedtke W., Ganella B., Mazzaccaro R.J., Clements J.M., Miller K.M., Wücherpfennig K.W., Gearing A.J.H., Raine C.S. Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors. Ann. Neurol. 44:1998;35-46.
46. Linsley P.S. Distinct roles for CD28 and cytotoxic T lymphocyte-associated molecule-4 receptors during T cell activation? J. Exp. Med. 182(2):1995;289-292.
47. Lovett-Racke A.E., Trotter J.L., Lauber J., Perrin P.J., June C.H., Racke M.K. Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells J. Clin. Invest. 101(4):1998;725-730.
48. Lyons P.D., Benveniste E.N. Cleavage of membrane-associated ICAM-1 from astrocytes: involvement of a metalloprotease. Glia. 22:1998;103-112.
49. Maeda A., Sobel R.A. Matrix metalloproteinases in the normal human central nervous system, microglial nodules and MS lesions. J. Neuropathol. Exp. Neurol. 55:1996;300-309.
50. Markovic-Plese S., Fukaura H., Zhang J., al-Sabbagh A., Southwood S., Sette A., Kuchroo V.K., Hafler D.A. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. J. Immunol. 155(2):1995;982-992.
51. Miller S.D., Vanderlugt C.L., Lenschow D.J., Pope J.G., Karandikar N.J., Dal Canto M.C., Bluestone J.A. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity. 3:1996;739-745.
52. Moingeon P., Chang H.C., Wallner B.P., Stebbins C., Frey A.Z., Reinherz E.L. CD2-mediated adhesion facilitates T lymphocyte antigen recognition function. Nature. 339:1989;312-314.
53. Mokhtarian F., McFarlin D.E., Raine C.S. Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice. Nature. 309(5966):1984;356-358.
54. Nielsen B.S., Timshel S., Kjeldsen L., Sehest M., Pyke C., Borregaard N., Dano K. Type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int. J. Cancer. 65:1996;57-62.
55. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity. 8:1998;275-283.
56. Ota K., Matsui M., Milford E.L., Mackin G.A., Weuner H.L., Hafler D.A. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature. 346:1990;183-187.
57. Prineas J.W., Raine C.S. Electron microscopy and immunoperoxidase studies of early multiple sclerosis lesions. Neurology. 26:1976;29-32.
58. Prineas J.W., Wright R.G. Macrophages, lymphocytes and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab. Invest. 38:1978;409-421.
59. Proost P., Van Damme J., Opdenakker G. Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein. Biochem. Biophys. Res. Commun. 192:1993;1175-1181.
60. Racke M.K., Scott D.E., Quigley L., Gray G.S., Abe R., June C.H., Perrin P.J. Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis. J. Clin. Invest. 96:1995;2195-2203.
61. Raine C.S. The Dale E. McFarlin memorial lecture: the immunology of the MS lesion. Ann. Neurol. 36:1994;S61-S72.
62. Raine C.S., Cannella B. Adhesion molecules and CNS inflammation. Semin. Neurosci. 4:1992;201-211.
63. Rao V.P., Kajon A.E., Spindler K.R., Carayanniotis G. Involvement of epitope mimicry in potentiation but not initiation of autoimmune disease. J. Immunol. 162:1999;5888-5893.
64. Romanic A.M., Madri J.A. The induction of a 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent. J. Cell Biol. 15:1994;1165-1178.
65. Rosenberg G.A., Kornfeld M., Estrada E., Kelley R.O., Liotta L.A., Stetler-Stevenson W.G. TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase. Brain Res. 576:1992;203-207.
66. Rosenberg G.A., Dencoff J.E., McGuire P.G., Liotta L.A., Stetler-Stevenson W.G. Injury-induced 92-kD gelatinase and urokinase expression in rat brain. Lab. Invest. 71:1994;417-422.
67. Rosenberg G.A., Dencoff J.E., Correa N., Reiners M., Ford C.C. Effect of steroids on CSF matrix metalloproteinases in MS: relation to blood-brain barrier injury. Neurology. 46:1996;1626-1632.
68. Sanchez-Madrid F., Nagy J.A., Robbins E., Simon P., Springer T.A. A human leukocyte differentiation antigen family with distinct β-subunits and a common α-subunit. J. Exp. Med. 158:1983;175-1803.
69. Scholz C., Patton K.T., Anderson D.E., Freeman G.J., Hafler D.A. Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation. J. Immunol. 160:1998;1532-1538.
70. Segal B.M., Dwyer B.K., Shevach E.M. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 187:1998;537-546.
71. Selmaj K., Raine C.S., Cannella B., Brosnan C.F. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87(3):1991;949-954.
72. Shrikant P., Chung I.Y., Ballestas M., Benveniste E.N. Regulation of ICAM-1 gene expression by TNF-α, IL-1-β and interferon-γ in astrocytes. J. Immunol. 151:1994;209-220.
73. Shrinkat P., Weber E., Jilling T., Benveniste E.N. ICAM-1 gene expression by glial cells: differential mechanisms of inhibition by IL-10 and IL-6. J. Immunol. 155:1995;1489-1501.
74. Siveke J.T., Hamann A. T helper 1 and T helper 2 cells respond differentially to chemokines. J. Immunol. 160(2):1998;550-554.
75. Sligh J.E. Jr., Ballantyme C.M., Rich S.S., Hawkins H.K., Smith C.W., Bradley A., Beaudet A.L. Inflammatory and immune responses are impaired in mice deficient in ICAM-1. Proc. Natl. Acad. Sci. U.S.A. 90:1993;8529-8533.
76. Sobel R.A., Mitchell M.E., Fondren G. ICAM-1 in cellular immune reactions in the human CNS. Am. J. Pathol. 136:1990;1309-1316.
77. Soilu-Hanninen M., Royna M., Salmi A., Salonen R. Therapy with antibody against leukocyte integrin VLA-4 (CD49d) is effective and safe in virus-facilitated EAE. J. Neuroimmunol. 72:1997;95-105.
78. Sorensen T.L., Tani M., Jensen J., Pierce V., Lucchinetti C., Folcik V.A., Qin S., Rottman J., Sellebjerg F., Strieter R.M., Frederiksen J.L., Ransohoff R.M. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patient. J. Clin. Invest. 103:1999;807-815.
79. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 76:1994;301-314.
80. Stone L.A., Frank J.A., Albert P.S.et al. The effect of interferon-beta on blood-brain barrier disruptions demonstrated by contrast-enhanced MRI in relapsing-remitting MS. Ann. Neurol. 37:1995;611-619.
81. Stuve O., Dooley N.P., Uhm J.H.et al. Interferon β-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann. Neurol. 40:1996;853-863.
82. Thompson C.B., Allison J.P. The emerging role of CTLA-4 as an immune attenuator. Immunity. 7(4):1997;445-450.
83. Tivol E.A., Schweitzer A.N., Sharpe A.H. Costimulation and autoimmunity. Curr. Opin. Immunol. 8(6):1996;822-830.
84. Van Der Voorn P., Tekstra J., Beelen R.H., Tensen C.P., Van Der Valk P., De Groot C.J. Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions. Am. J. Pathol. 154:1999;45-51.
85. Walsh M.J., Murray J.M. Dual implication of 2′,3′-cyclic nucleotide 3′ phosphodiesterase as major autoantigen and C3 complement-binding protein in the pathogenesis of multiple sclerosis. J. Clin. Invest. 101:1998;1923-1931.
86. Washington R., Burton J., Todd R.F. III, Newman W., Dragovic L., Dore-Duffy P. Expression of immunologically relevant endothelial cell activation antigens on isolated CNS vessels from patients with MS. Ann. Neurol. 35:1994;89-97.
87. Williams K., Ulvestad E., Antel J.P. B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ. Eur. J. Immunol. 24:1994;3031-3037.
88. Windhagen A., Newcombe J., Dangond F., Strand C., Woodroofe M.N., Cuzner M.L., Hafler D.A. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 182:1995;1985-1996.
89. Windhagen A., Anderson D.E., Carrizosa A., Balashov K., Weiner H.L., Hafler D.A. Cytokine secretion of myelin basic protein reactive T cells in patients with multiple sclerosis. J. Neuroimmunol. 91:1998;1-9.
90. Woessner J.F. Jr. The family of matrix metalloproteinases. Ann. N. Y. Acad. Sci. 732:1994;11-21.
91. Wucherpfennig K.W., Strominger J.L. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 80:1995;695-705.
92. Yednock T.A., Cannon C., Fritz L.C., Sanchez-Madrid F., Steinman L., Karin N. Prevention of EAE by antibodies against α4β1 integrin. Nature. 356:1992;63-66.
93. Yong V.W., Krekowski C.A., Forsyth P.A., Bell R., Edwards D.R. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 21:1998;75-80.
94. Zamvil S., Nelson P., Trotter J., Mitchell D., Knobler R., Fritz R., Steinman L. T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. Nature. 317(6035):1985;355-358.
95. Zhang J., Markovic-Plese S., Lacet B., Raus J., Weiner H.L., Hafler D.A. Increased frequency of interleukin 2-responsive T cell specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J. Exp. Med. 179:1994;973-984.
96. Zhao Z.S., Gramicci F., Yeh L., Schaffer P.A., Cantor H. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science. 279:1998;1344-1347.